Blue Owl Capital Co-CEO Marc Lipschultz discusses earnings after joining forces with Meta on AI dats centers as it continues to reinforce its long term pipline. Lipschultz spoke with Bloomberg's Dani Burger and Matt Miller.

Blue Owl Capital Co-CEO Marc Lipschultz discusses earnings after joining forces with Meta on AI dats centers as it continues to reinforce its long term pipline. Lipschultz spoke with Bloomberg's Dani Burger and Matt Miller.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Blue Owl Capital Co-CEO Marc Lipschultz Talks Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e6db164b-b85a-4659-9774-b38700fc1ffe/transcript

Connecticut Governor Ned Lamont discusses the Trump administration's suspension of offshore wind farm leases, which includes a farm that was intended to power thousands of Connecticut homes. Lamont elaborates on his opinion of the suspension and how it will affect energy prices in Connecticut.

Connecticut Governor Ned Lamont discusses the Trump administration's suspension of offshore wind farm leases, which includes a farm that was intended to power thousands of Connecticut homes. Lamont elaborates on his opinion of the suspension and how it will affect energy prices in Connecticut.

Connecticut Governor Talks Suspension of Wind Farm Leases

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b6ecf482-425d-4cce-aeeb-b3bc01573ba0/transcript

Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Novo Nordisk President &amp; CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Novo Nordisk President and CEO Talks Wegovy Pill

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/1401461b-2451-4711-93ca-b3bc00fdb697/transcript

Bank of America Chair & CEO Brian Moynihan tells Wall Street Week's David Westin that artificial intelligence is starting to have a bigger impact on the US economy. In a wide ranging conversation, Moynihan also talks about his outlook for the economy in 2026, immigration, the Fed and more. 

 

Bank of America Chair &amp; CEO Brian Moynihan tells Wall Street Week's David Westin that artificial intelligence is starting to have a bigger impact on the US economy. In a wide ranging conversation, Moynihan also talks about his outlook for the economy in 2026, immigration, the Fed and more.&nbsp;
&nbsp;

Bank of America CEO Brian Moynihan Talks 2026 Outlook, AI & More

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/65c9bafd-39e3-495c-97d5-b3bc00095285/transcript

Blue Owl Capital Co-CEO Marc Lipschultz Talks Earnings

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips